As attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Saptak Chem and Business Ltd approved unaudited results for the quarter and half year ended September 30, 2025. The company reported zero revenue from operations and a net loss of Rs. 1.89 lakhs for Q2 and Rs. 7.79 lakhs for H1 FY26. The company also accepted the resignation of Statutory Auditor Mr. Meet Shah (citing pre-occupation and location) and appointed M/s. P H Shah & Co as the new Statutory Auditor to fill the casual vacancy until the next AGM. Notably, the company recently completed a 90% capital reduction (approved by NCLT in June 2025) to write off accumulated losses of around Rs. 9.66 crores.
This is a micro-cap company with zero revenue, recurring losses, negative net worth (Rs. -233 lakhs), and is borrowing to meet even its basic operating expenses. The mid-year change of statutory auditors and a 90% capital reduction to wipe out past losses raise red flags about the company's financial health. Shareholders should view this stock with high caution as going-concern issues appear evident.